About Invibio® Biomaterial Solutions
Invibio Biomaterial Solutions is your dependable, specialized, and comprehensive resource to help you develop the best possible medical device solutions and bring them to market quickly. We are an established, worldwide leader in biomaterial solutions for the surgical and medical device markets, offering proven biocompatible PEEK polymers:
- PEEK-OPTIMA® polymer and compounds
- MOTIS® polymer
- ENDOLIGN® composite
- PEEK-CLASSIX® polymer
Invibio is the market leader in providing PEEK-based biomaterial solutions to medical device manufacturers around the world. Our powerful array of value-added services provide our customers with comprehensive solutions that include: dependable, traceable product supply; technical, developmental, processing, and regulatory support services; and knowledgeable customer service support to help ensure your product’s success.
Track Record of Innovation
Invibio Biomaterial Solutions, founded in 2001, is dedicated to helping medical device manufacturers create, develop, manufacture, and sell products of exceptional quality.Some of the milestones along our corporate journey include:
- February 2009 – Invibio introduces MOTIS® polymer, an enhanced polyetheretherketone (PEEK) polymer with properties specifically tailored for articulating and bearing applications against hard counterfaces.
- May 2008 – Invibio and Smith & Nephew enter into a collaboration program to develop advanced structural bioresorbable materials with the performance specifications needed for more rigid, load bearing applications typically not attainable by today's resorbable biomaterial technologies.
- November 2007 – Fresenius Kabi, a leading provider of infusion and clinical nutrition therapies, specifies Invibio PEEK-OPTIMA polymer for a new implantable port access system due to the biocompatibility, mechanical properties, and processing capabilities of the biomaterial.
- September 2007 – Invibio launches Image Contrast Grade of PEEK-OPTIMA polymer that allows optimal device and healing site visualization with X-ray, CT, and MRI imaging modalities.
- April 2007 – Research presented at the Society for Biomaterials indicates that the cellular response of human primary osteoblasts to Invibio PEEK-OPTIMA polymer is comparable to Grade 1 commercially pure titanium.
- March 2007 – PEEK-OPTIMA polymer becomes the platform for a new generation of non-metallic and non-ceramic biomaterials from Dentanium Technologies AG for use in oral applications including crowns, bridges, implants, and attachments.
- February 2007 – The first orthopaedic implant using Invibio carbon fiber-reinforced (CFR) PEEK-OPTIMA compound receives regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW).
- February 2007 – Invibio launches carbon fiber-reinforced (CFR) PEEK-OPTIMA compound which offers enhanced strength, wear properties, and imaging compatibility for load bearing applications requiring blood, bone or tissue contact of more than 30 days.
- January 2007 – Invibio opens dedicated Global Technical Center in the United Kingdom that houses processing facilities, testing laboratories, and a Class 10000 clean room, ensuring contaminate-free manufacturing capabilities for research and development grades as well as prototype materials.
- September 2006 – Invibio launches ENDOLIGN polymer, a metal replacement for use in the development of long-term implantable load bearing medical device applications.
- June 2006 – Invibio presents research investigating wear rates of carbon fiber-reinforced (CFR) PEEK polymer, which indicates orthopaedic implants developed with CFR PEEK polymer may produce less wear compared to those implants developed using conventional UHWMPE-on-metal material combinations.
- February 2006 – Invibio receives prestigious 2005 Product Innovation of the Year Award for polymeric materials in the medical implant market from Frost & Sullivan.
- September 2005 – The Japanese Ministry of Health, Labour and Welfare (MHLW) approves the first implantable medical device manufactured with PEEK-OPTIMA polymer– an arthroscopy device – for commercialization in Japan.
- January 2004 - Invibio introduces PEEK-CLASSIX polymer for use in the development of short-term (up to 30 days) tissue contact medical device and pharmaceutical applications.
- April 2003 - Invibio achieves ISO 13485 compliance (cGMP) for the manufacture of PEEK-OPTIMA polymer.
- May 2002 - Lifecore Biomedical selects Invibio PEEK-OPTIMA polymer for the development of its healing abutment dental caps.
- June 2001 - The first major spinal implant manufacturers select Invibio PEEK-OPTIMA polymer for development of interbody fusion cages.
- April 2001 – Invibio Biomaterial Solutions formed as a wholly owned subsidiary of Victrex plc to focus exclusively on the medical device market.
- September 2000 – Invibio executes the first European long-term Supply Assurance Agreement for PEEK-OPTIMA polymer.
- August 1999 – First PEEK-OPTIMA polymer long-term Supply Assurance Agreement executed with a U.S. device manufacturer.
- June 1999 - Launch of PEEK-OPTIMA polymer at the Medical Device & Manufacturing Meeting.
Contact Invibio to learn more about our Biomaterial Solutions.